6
Participants
Start Date
July 14, 2014
Primary Completion Date
December 20, 2017
Study Completion Date
December 20, 2017
Carfilzomib
Starting dose: 20 mg/m2 by vein on Days 1 and 2 in Cycle 1 followed by 56 mg/m\^2 for each subsequent dose thereafter) on days 1 and 2, 8 and 9, 15 and 16 of a 28-day cycle (following cycle 12 carfilzomib given on days 1 and 2 and 15 and 16 only).
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Onyx Therapeutics, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER